{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T17:15:08Z","timestamp":1783962908784,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.imlet.2012.02.012","type":"journal-article","created":{"date-parts":[[2012,2,28]],"date-time":"2012-02-28T13:31:43Z","timestamp":1330435903000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pathogenesis of lupus-like nephritis through autoimmune antibody produced by CD180-negative B lymphocytes in NZBWF1 mouse"],"prefix":"10.1016","volume":"144","author":[{"given":"Kazuko","family":"Fujita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikiyo","family":"Akasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Yokoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami","family":"Iuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Akishima-Fukasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motonari","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiharu","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2012.02.012_bib0005","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri1957","article-title":"Toll-like receptors in systemic autoimmune disease","volume":"6","author":"Marshak-Rothstein","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.imlet.2012.02.012_bib0010","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1002\/art.22197","article-title":"Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process","volume":"54","author":"Papadimitraki","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2012.02.012_bib0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.smim.2011.01.016","article-title":"Toll-like receptor driven B cell activation in the induction of systemic autoimmunity","volume":"23","author":"Green","year":"2011","journal-title":"Semin Immunol"},{"key":"10.1016\/j.imlet.2012.02.012_bib0020","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/416603a","article-title":"Chromatin-IgG complexes activate B cells by dual engagement of IgM and toll-like receptors","volume":"416","author":"Leadbetter","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2012.02.012_bib0025","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.4049\/jimmunol.0902592","article-title":"TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus","volume":"184","author":"Nickerson","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2012.02.012_bib0030","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jaut.2010.07.007","article-title":"Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes","volume":"35","author":"Lee","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.imlet.2012.02.012_bib0035","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.4049\/jimmunol.0803219","article-title":"Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus","volume":"183","author":"Lartigue","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2012.02.012_bib0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1084\/jem.188.1.93","article-title":"The molecular mechanism of B cell activation by toll-like receptor protein RP-105","volume":"188","author":"Chan","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2012.02.012_bib0045","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/ni1198","article-title":"Negative regulation of toll-like receptor 4 signaling by the toll-like receptor homolog RP105","volume":"6","author":"Divanovic","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.imlet.2012.02.012_bib0050","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1084\/jem.180.4.1217","article-title":"Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells","volume":"180","author":"Miyake","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2012.02.012_bib0055","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.4049\/jimmunol.154.7.3333","article-title":"RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family","volume":"154","author":"Miyake","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2012.02.012_bib0060","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/geno.1996.0632","article-title":"Molecular cloning of a human RP105 homologue and chromosomal localization of the mouse and human RP105 genes (Ly64 and LY64)","volume":"38","author":"Miura","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.imlet.2012.02.012_bib0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1084\/jem.184.1.113","article-title":"Activation mediated by RP105 but not CD40 makes normal B cells susceptible to anti-IgM-induced apoptosis: a role for fc receptor coligation","volume":"184","author":"Yamashita","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2012.02.012_bib0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jlb.65.1.43","article-title":"Anti-human RP105 sera induces lymphocyte proliferation","volume":"65","author":"Roshak","year":"1999","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.imlet.2012.02.012_bib0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1084\/jem.192.1.23","article-title":"The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells","volume":"192","author":"Ogata","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2012.02.012_bib0080","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1189\/jlb.0107021","article-title":"Regulation of TLR4 signaling and the host interface with pathogens and danger: the role of RP105","volume":"82","author":"Divanovic","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.imlet.2012.02.012_bib0085","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1002\/1529-0131(199912)42:12<2593::AID-ANR12>3.0.CO;2-G","article-title":"B cells lacking RP105, a novel B cell antigen, in systemic lupus erythematosus","volume":"42","author":"Koarada","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2012.02.012_bib0090","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/ard.60.12.1137","article-title":"Difference in B cell activation between dermatomyositis and polymyositis: analysis of the expression of RP105 on peripheral blood B cells","volume":"60","author":"Kikuchi","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.imlet.2012.02.012_bib0095","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/rheumatology\/40.11.1315","article-title":"CD180 (RP105) in rheumatic diseases","volume":"40","author":"Koarada","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.imlet.2012.02.012_bib0100","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1002\/art.10672","article-title":"RP105-lacking B cells from lupus patients are responsible for the production of immunoglobulins and autoantibodies","volume":"46","author":"Kikuchi","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2012.02.012_bib0105","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/rheumatology\/kep437","article-title":"Autoantibody-producing RP105(-) B cells, from patients with systemic lupus erythematosus, showed more preferential expression of BCMA compared with BAFF-R than normal subjects","volume":"49","author":"Koarada","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.imlet.2012.02.012_bib0110","first-page":"562","article-title":"Two cases of antinuclear antibody negative lupus showing increased proportion of B cells lacking RP105","volume":"32","author":"Koarada","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.imlet.2012.02.012_bib0115","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1002\/1521-4141(200109)31:9<2726::AID-IMMU2726>3.0.CO;2-H","article-title":"Inflamed kidneys of NZB\/W mice are a major site for the homeostasis of plasma cells","volume":"31","author":"Cassese","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.imlet.2012.02.012_bib0120","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.4049\/jimmunol.0901652","article-title":"Anti-programmed cell death 1 antibody reduces CD4+PD-1+T cells and relieves the lupus-like nephritis of NZB\/W F1 mice","volume":"184","author":"Kasagi","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2012.02.012_bib0125","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/ki.1986.105","article-title":"Characterization of mononuclear cell subsets in renal cellular interstitial infiltrates","volume":"29","author":"Boucher","year":"1986","journal-title":"Kidney Int"},{"key":"10.1016\/j.imlet.2012.02.012_bib0130","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ki.1990.14","article-title":"Lupus nephritis: correlation of interstitial cells with glomerular function","volume":"37","author":"Alexopoulos","year":"1990","journal-title":"Kidney Int"},{"key":"10.1016\/j.imlet.2012.02.012_bib0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00281-006-0030-7","article-title":"Genetics of SLE in mice","volume":"28","author":"Kono","year":"2006","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.imlet.2012.02.012_bib0140","first-page":"1","article-title":"Murine models of systemic lupus erythematosus","volume":"2","author":"Perry","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.imlet.2012.02.012_bib0145","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1038\/sj.onc.1203551","article-title":"Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors","volume":"19","author":"Hirano","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.imlet.2012.02.012_bib0150","series-title":"Laboratory methods in histotechnology","first-page":"53","article-title":"Hematoxylin and eosin","author":"Alleen","year":"1994"},{"key":"10.1016\/j.imlet.2012.02.012_bib0155","series-title":"Laboratory methods in histotechnology","article-title":"Periodic acid shiff procedure","author":"Gaffney","year":"1994"},{"key":"10.1016\/j.imlet.2012.02.012_bib0160","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nri2869","article-title":"The immune tolerance network at 10 years: tolerance at the bedside","volume":"10","author":"Bluestone","year":"2010","journal-title":"Nat Rev Immunol"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247812000624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247812000624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:33:14Z","timestamp":1759044794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247812000624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":32,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0165247812000624"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2012.02.012","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenesis of lupus-like nephritis through autoimmune antibody produced by CD180-negative B lymphocytes in NZBWF1 mouse","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2012.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}